Skip to main content
Article thumbnail
Location of Repository

Metabolic support in left ventricular hypertrophy

By Neil John Howell

Abstract

Aims: To examine the metabolic changes associated with LVH secondary to AS, to examine the role of GIK as an adjunct to myocardial protection during AVR, and to examine the mechanism of its action. Methods: 220 patients with LVH secondary to AS were randomised 1:1 to receive an infusion of GIK at the time of AVR. The primary endpoint of the trial was incidence of low cardiac output state. At pre-specified time points, biopsies of the LV anterior wall were taken for analysis of metabolic changes associated with LVH, and changes in the phosphorylation state of proteins identified as key regulators of metabolism and cardiac protection. Results: Patients with LVH were found to exhibit a profound down-regulation of the mRNA transcript levels of the master transcriptional regulators of metabolism resulting in a significantly abnormal metabolome. Treatment with GIK was associated with a reduction in LCOS from 33% in the control group to 10% in the treatment group, p=0.0001. Treatment with GIK was associated with a significant increase in the level of protein O-GlcNAcylation. Conclusions: In this trial, treatment with GIK was associated with a significant improvement in post-operative haemodynamics. Patients with LVH may benefit from metabolic therapies at the time of surger

Topics: RC Internal medicine
Year: 2011
OAI identifier: oai:etheses.bham.ac.uk:1492

Suggested articles

Citations

  1. A new look at the biogenesis of glycogen. doi
  2. Abnormal ventricular intracavity flow acceleration in patients undergoing aortic valve replacment for aortic stenosis: a marker for high postoperative morbidity and mortality.
  3. Absolute concentrations of high energy phosphate metabolites in normal hypertrophied and failing human myocardium measured non-invasively with (31) SLOOP magnetic resonance spectrscopy. doi
  4. Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake.
  5. Adrenaline induced oxygen wastage and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid and coronary ligation.
  6. (1976). Afterload mismatch and preload reserve: A conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis. doi
  7. (1981). Alterations of carbohydrate and lipid metabolism in the acuteli ischemic heart. Prog Cardiovasc Dis.
  8. (2005). AMP-activated protein kinase: a key stress signalling pathway in the heart. Trends Cardiovasc Med.
  9. An imbalance bewteen glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic perfusion of ischemic hearts.
  10. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction: prognostic indicators.
  11. Aortic valve stenosis: Comparison of patients to those without congestive heart failure. doi
  12. (1995). ATPase abolishes the protection afforded by glycolysis against myocardial ischemic injury.
  13. Cardiac ATP-sensitive K+ channels. Evidence for preferential regulation by glycolysis. doi
  14. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res.
  15. (1996). Characterisation of 5'-AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochem Biophys Acta.
  16. (1996). Contribution of glycogen to aerobic myocardial glucose utilisation. doi
  17. (1994). Contribution to oxidative metabolism and glycolysis to ATP production in hypertrophied hearts.
  18. Control of glucose utilization in working perfused rat hearts.
  19. (1979). Control of maximum rates of glycolysis in rat cardiac muscle. Circ Res.
  20. Coronary sinus blood flow at rest and during isometric exercise in patients with aortic valve disease. Mechanisms of angina pectoris in the presence of normal coronary arteries.
  21. Creatine kinase of heart mitochondria. The progressive loss of enzyme activity during in vivo ischemia and its correlation to depressed myocardial function.
  22. Demonstration of an imbalance between coronary perfusion and excessive load as a mechanism of ischemia during stress in patients with aortic stenosis.
  23. Depressed high-energy phosphate content in hypertrophied ventricles of animal and man: the biologic basis for increased sensitivity to ischemic injury. Ann Surg.
  24. Detection of low phosphocreatinine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.
  25. Determinants of ventricular function in pressure overload hypertrophy in man. doi
  26. Diastolic dysfunction in aortic stenosis.
  27. Dual mechanisms regulating AMP Kinase action in the ischemic heart. Circ Res.
  28. Early diastolic left ventricular function in aortic stenosis.
  29. Effects of fatty acids in isolated mitochondria: implications for ischemic injury.
  30. Effects of heart work and insulin on glycogen metabolism in the perfused rat heart.
  31. Expression profiling reveals a distinct set of genes altered during induction and regression of cardiac hypertrophy.
  32. (1972). Factors determining myocardial oxygen consumption during elevation of aortic blood pressure. Relationship with free fatty acids. Cardiovasc Res.
  33. Fatty acid oxidation enzyme gene expression is donwnregulated in the failing heart.
  34. (1986). Fuel selection in animals. Biochem Soc Trans.
  35. Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. doi
  36. Genome wide expression profiling of a cardiac pressure overload model identifies major metabolic signaling pathway responses.
  37. Gioradano FJ. AMP-activated protein kinase mediates glucose uptake and prevents post ischemic injury.
  38. Glcuose transport and phosphorylation in single cardiac myocytes: rate limiting step in glucose metabolism.
  39. (1990). Glucose and palmitate oxidation in isolated working rat hearts perfused after a period of global transient ischemia. Circ Res.
  40. (1981). Glucose metabolism during ischemia due to excessive oxygen demand or altered coronary flow in the isolated arterially perfused rabbit septum. Circ Res.
  41. (1983). Glycogen and lipds (endogenous substrates).
  42. (1995). High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with decrease in malonyl CoA levels due to an increase in 5'-AMP activated protein kinase inhibition of acetyl-CoA carboxylase.
  43. (1994). Impact of chamber geometry and gender on left ventricular function in patients with aortic stenosis.
  44. Increased myocardial oxygen consumtion reduces cardiac efficiency in diabetic mice.
  45. (1999). Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res.
  46. Is the failing heart energy starved? On chemical energy to support cardiac function. Circ Res.
  47. (1994). Ischemia induces translocation of the insulin responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes Circulation
  48. (2004). Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 upregulation in the late phase of cardioprotection. Cardiovasc Res.
  49. Kostin S et al Progression from compensated hypertrophy to failure in the pressure overload human heart; structural deterioration and compensatory mechanisms. doi
  50. Left ventricular function in aortic stenosis.
  51. Left ventricular hypertrophy in aortic valve stenosis: preventative or promotive of systolic dysfunction and heart failure. doi
  52. Left ventricular wall stress in compensated aortic stenosis. doi
  53. Mechanism of diastolic dysfunction induced by glycolytic inhibition
  54. (1975). Mechanism of glycolytic inhibition in ischemic rat hearts. Circ Res.
  55. Mechanisms of coronary microcirculatory dyfunction in patients with aortic stenosis and normal coronary arteries.
  56. Metabolic fate of extracted glucose in normal human myocardium. doi
  57. Metabolic gene expression in fetal and failing human heart.
  58. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes.
  59. (1990). Molecular Biology of mammalian glucose transporters. Diabetes Care.
  60. Molecular cloning and characterisation of an insulin regulatable glucose transporter.
  61. Myocardial contractile function in aortic stenosis as determined from the rate of stress development during isovolumic systole. doi
  62. (1992). Myocardial fatty acid oxidation during ischemia and reperfusion. Mol Cell Biochem.
  63. Myocardial free fatty acid and glucose use after Carvedilol treatment in patients with congestive heart failure. doi
  64. (1991). Myocardial lactate metabolism during exercise. Med Sci Sport Exerc.
  65. Myocardial lactate release during ischemia in swine. Relation to regional blood flow.
  66. Myocardial structure and function in patients with aortic valve disease and their relationship to post-operative results.
  67. (2005). Myocardial substrate metabolism in the normal and failing heart. Physiol Rev.
  68. Myocardial substrate metabolism influences left ventricular energetics in vivo.
  69. Myocardial substrate utilization during exercise in humans: dual carbon-labelled carbohydrate isotope experiments. doi
  70. (1992). Myocardial triglyceride turnover during reperfusion of isolated rate hearts subjected toa transient period of global ischemia.
  71. (1995). Normalisation of diastolic dysfunction in aortic stenosis late after valve replacement Circulation. doi
  72. (1998). Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury. Circ Res.
  73. (1980). Oxfenicine diverts rat muscle metabolism from fatty acid to carbohydrate oxidation and protects the ischemic rat heart. Life Sci. doi
  74. (1980). Oxygen consumption in subepicardial and subendocardial regions of the canine left ventricle - The effect of experimental acute valvular aortic stenosis. Circ Res.
  75. Phosphorylation and activation of heart PFK2 by AMPK has a role in the stimulation of glycolysis during ischemia.
  76. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell metabolism.
  77. (2006). Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal Chem.
  78. Progression of heart failure: A role for interstitial fibrosis. Mol Cell Biochem. doi
  79. Progressive loss of myocardial ATP due to loss of total purines during the development of heart failure. doi
  80. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure.
  81. (1991). Protons in ischemia: Where do they come from; where do they go to? J Mol Cell Cardiol.
  82. (1989). Purification and characterisation of the AMP-activated protein kinase Eur
  83. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: Effect of dichloroacetate.
  84. (2002). Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts. Cardiovasc Res.
  85. (1995). Pyruvate dehydrogenase influences postischemic heart function.
  86. (1990). Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res.
  87. (1995). Regulation of glucose metabolism in cardiac muscle Biochem Soc Trans.
  88. Regulation of glucose uptake by muscle. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles.
  89. (1997). Regulation of myocardial carbohydrate metabolism under normal and ischemic conditions: Potential for pharmacological interventions. Cardiovasc Res.
  90. Regulation of pyruvate dehydrogenase. doi
  91. Relationship between glycolysis and and calcium homeostasis in post ischemic myocardium. Circ Res.
  92. (1978). Relative importance of pyruvate dehydrogenase interconversion on the feedback inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. Arch Biochem Biophys. doi
  93. Role of fructose 2,6,-bisphosphate in the control of heart glycolysis.
  94. (2006). Shah A et al. H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart. Circ Res.
  95. Sustained nonoxidative glucose utilisation and depletion of glycogen in reperfused canine myocardium.
  96. (1995). Taegtmeyer H Glycogen turnover in the isolated working rat heart. doi
  97. The AMP-activated protein kinase - fuel gage of the mammalian cell?
  98. The creatine kinase system in normal and diseased human myocardium. doi
  99. The effects of hypertrophy and diabetes on cardiac pyruvate dehydrogenase activity.
  100. The failing heart: an engine out of fuel.
  101. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus. doi
  102. (1991). The Heart: Physiology and metabolism.
  103. The molecular energetics of the failing heart from animal studies. Heart Failure Reviews.
  104. The role of left atrial transport in aortic and mitral stenosis.
  105. The sodium/hydrogen exchange system in cardiac cells: Its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH.
  106. (1995). Translocation of glucose transporter isoforms in vivo: effects of hyper-insulinemia and low flow ischemia in the canine heart.
  107. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat.
  108. (1990). Transmural differences in energy metabolism of the left ventricular myocardium: fact or fiction? J Mol Cell Cardiol.
  109. (1987). Transmural myocardial perfusion Prog Cardiovasc Dis.
  110. (1996). Uncoupling of contractile function from mitochondria TCA cycle activity and oxygen consumption during reperfusion of ischemic rat hearts.
  111. Uncoupling proteins in the human heart.
  112. Ventricular performance, pump function and compensatory mechanisms in patients with aortic stenosis. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.